Competitive Technologies, Inc. (CTTC: OTC PK), headquartered in Fairfield, Connecticut, offers technology transfer services. CTTC licenses technologies from clients, obtaining licenses or rights to intellectual property on a broad array of technologies from universities, companies, inventors and patent or intellectual property holders. The company’s intellectual property portfolio includes rights to technology in life sciences (healthcare), electronics, nano science and physical sciences.
Licenses and rights licensed by CTTC from clients are in turn licensed or sub-licensed to customers, including large multinationals seeking to augment their product development efforts and enlarge their pipelines. Customers pay CTTC license fees, royalties, or a share of per procedure or per unit revenue. Since its inception, CTTC has licensed nearly 500 technologies to corporations and shared over $100 million in shared technology revenues with universities and inventors.
Near-term growth efforts are based on the commercialization of a medical device that CTTC acquired rights to in 2007. The product, FDA-approved and CE marked, is eligible for regulatory clearance in most of the world’s medical markets. The MC5-A, also known as the Calmare Pain Therapy device, could potentially gain wide acceptance as a treatment for neuropathic and oncologic pain that has not responded to pharmaceutical or other device-based pain therapy.